2013 - IXA 2013 Congress


This page contains exclusive content for the member of the following sections: TTS, IXA. Log in to view.

Joint IXA/JEXSWINE Plenary Session: Update on Genetic Engineering- Tg Pigs & Tissue Engineering - Part 2 (Sponsored by Astellas)

38.1 - Part 2: Tissue Engineering - Porcine iPS

Presenter: Yutaka, Hanazono, Brussels, Japan
Authors:

 

Xenogeneic in Utero Transplantation For Generation of Animals Producing Human Blood Cells

Yutaka Hanazono, MD, PhD

Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University

 

A major barrier for most tissue or cellular transplantation therapies is the shortage of donors.  That is also the case with the supply of red blood cells, platelets and hematopoietic stem cells.  Our study aims to produce human blood cells from induced pluripotent stem (iPS) cells in vivo in animals.  Human iPS cells have remarkable abilities to proliferate indefinitely and differentiate into multiple tissue and blood cells.  In addition, iPS cells can be generated from adult skin or peripheral blood cells without complicated ethical issues.  Therefore, directed differentiation of human iPS cells into functionally defied human blood cells is a goal in providing an inexhaustible and potentially customized supply of the cells.  Clearly directed differentiation of human iPS cells is still in its infancy and the methodology is quite limited.  Many researchers have studied in vitro specific differentiation programs through manipulation of the cytokine milieu, cellular microenvironment, and conditional activation of specific gene expression.  Despite these efforts, neither hematopoietic stem cells nor red blood cells nor platelets can be efficiently produced from iPS cells in vitro.  Another strategy to produce human blood cells from iPS cells would be the utilization of in vivo local microenvironment or niche in animals.  In this context, we are conducting sheep in utero transplantation (IUT) of human hematopoietic stem or precursor cells to generate animals producing human blood cells.  Large animals would be able to produce a large number of human blood cells taking advantage of their sizes compared to rodents.  Among large animals, sheep have some advantages; relative ease of handling and low abortion rates after IUT.  Pigs are also good candidates.  I will review our previous studies and show some of preliminary results.

 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada